Vimarsana
Biggest News Aggregation in the World

Page 22 - Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recursion Pharmaceuticals Today - Breaking & Trending Today

Before the Bell: ASX to rise, data bolster case for June quarter rate cut - Vimarsana News

Before the Bell: ASX to rise, data bolster case for June quarter rate cut

Australian shares are set to open higher, as commodities rebounded. Japan, UK and US data signal weakness. Dow paces Wall Street advance.

Source: afr.com
Why Is Recursion Pharmaceuticals Stock Trading Higher Today? - Vimarsana News

Why Is Recursion Pharmaceuticals Stock Trading Higher Today?

Recursion Pharmaceuticals Inc RXRX shares are trading higher after Nvidia Corp NVDA, in its 13F filing, disclosed a small stake in the company. As per the SEC…

Source: biztoc.com
Nvidia reveals small holding in Arm - Vimarsana News

Nvidia reveals small holding in Arm

Nvidia disclosed it has built up a stake in SoftBank Group-owned Arm worth more than $147 million, a move which comes two years after it walked away form a deal to acquire the chip designer outright for $40 billion.

AI stocks rally after Nvidia reveals stake, SoundHound rockets 50%, Guardforce up 11% - Vimarsana News

AI stocks rally after Nvidia reveals stake, SoundHound rockets 50%, Guardforce up 11%

The rally showed Nvidia's growing influence in the AI world as its market value grows at a scorching pace, making it the third most-valuable US company

nvidia stock target: AI firms surge after chip giant Nvidia discloses stake - Vimarsana News

nvidia stock target: AI firms surge after chip giant Nvidia discloses stake

The rally showed Nvidia's growing influence in the AI world as its market value grows at a scorching pace, making it the third most-valuable U.S. company. Its largest investment of $147.3 million was in Arm Holdings, the chip designer that Nvidia failed to buy after the $80 billion deal hit the antitrust hurdle two years ago.